Sample Collection From Melanoma Patients

NCT00507325 | Terminated

• 1 other identifier: 2005-0466
• Study Type: observational
• Target: 131
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this laboratory research study is to collect blood and tumor samples from patients with malignant melanoma. Researchers want to store these samples in a secure and confidential laboratory at M. D. Anderson. Researchers will use the information that is learned in this study to help find ways to improve treatment for melanoma and other cancers.

Conditions

Melanoma

Keywords

Malignant Melanoma; Blood Sample; Tumor Sample; Long-term storage; Sample Collection

Outcome Measures

Primary Outcomes (1)

• Collection and long-term collection of blood and tumor samples from patients with malignant melanoma for future biological and/or surrogate marker studies.

  6 Years

Study Arms (1)

Blood Sample + Tumor Sample

Blood samples will be collected. Tumor samples will be collected using a small needle, a punch knife, or a small surgery.

Procedure: Blood Sample; Procedure: Tumor Sample

Interventions

Blood Sample PROCEDURE

Blood samples will be collected.

Blood Sample + Tumor Sample

Tumor Sample PROCEDURE

Tumor samples will be collected using a small needle, a punch knife, or a small surgery.

Blood Sample + Tumor Sample

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Study participants with a diagnosis of malignant melanoma.

You may qualify if:

• Patients with a suspected or confirmed diagnosis of malignant melanoma. These include patients with melanoma of the soft part, spindle-cell neoplasm consistent with melanoma and choroidal melanoma.
• Patients who are willing to consent for this protocol.

Sponsors & Collaborators

• M.D. Anderson Cancer Center: lead

Study Sites (1)

University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

• University of Texas MD Anderson Cancer Center Website

Biospecimen

Retention: SAMPLES WITH DNA

Patients will provide blood and tumor samples to help researchers learn about melanoma and other cancers.

MeSH Terms

Conditions

Melanoma; Neoplasms

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

Neuroendocrine Tumors; Neuroectodermal Tumors; Neoplasms, Germ Cell and Embryonal; Neoplasms by Histologic Type; Neoplasms, Nerve Tissue; Nevi and Melanomas; Skin Neoplasms; Neoplasms by Site; Skin Diseases; Skin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Specimen Handling; Clinical Laboratory Techniques; Diagnostic Techniques and Procedures; Diagnosis; Punctures; Surgical Procedures, Operative; Investigative Techniques

Study Officials

• Michael Davies, MD

  M.D. Anderson Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 24, 2007
• First Posted: July 26, 2007
• Study Start: June 13, 2006
• Primary Completion: August 1, 2022
• Study Completion: August 1, 2022
• Last Updated: September 2, 2022

Record last verified: 2022-08

Locations

US (1)